Compile Data Set for Download or QSAR
Report error Found 1355 with Last Name = 'robertson' and Initial = 'ad'
TargetD(2) dopamine receptor(Rat)
Wellcome Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50033383((S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)m...)
Affinity DataKd:  0.0400nMAssay Description:Binding affinity against Dopamine receptor D2 in rat striatum using [3H]-spiperone as radioligandMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 1B(Human)
Wellcome Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50033383((S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)m...)
Affinity DataKd:  1.5nMAssay Description:Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetD(1A) dopamine receptor(Rat)
Wellcome Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50033383((S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)m...)
Affinity DataKd:  0.300nMAssay Description:Binding affinity against dopamine receptor D1 in rat striatum using [3H]SCH-23390 as radioligandMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 1A(Human)
Wellcome Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50033383((S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)m...)
Affinity DataKd:  1.80nMAssay Description:Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endotheliumMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 1D(Human)
Wellcome Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50033383((S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)m...)
Affinity DataKd:  1.5nMAssay Description:Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM10755([3H]-5-HT | 5-Hydroxy Tryptamine | 2-imino-1-methy...)
Affinity DataEC50:  1.63nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379801(CHEMBL2011548)
Affinity DataEC50:  2.00E+3nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379810(CHEMBL2011553)
Affinity DataEC50:  1.26E+3nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379800(CHEMBL2011556)
Affinity DataEC50:  790nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379819(CHEMBL2011564)
Affinity DataEC50:  128nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50036718(CHEMBL1901802 | 4-phenyl-1,2,3,6-tetrahydropyridin...)
Affinity DataEC50:  2.45E+3nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379821(CHEMBL2011565)
Affinity DataEC50:  158nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50036712(CHEMBL101664 | CHEMBL2011566 | 4-(4-Chloro-phenyl)...)
Affinity DataEC50:  1.76E+3nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379822(CHEMBL2011567)
Affinity DataEC50:  72.3nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50379823(CHEMBL2011569)
Affinity DataEC50:  3.52E+3nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM31023(CHEMBL2011570 | SMR000029333 | MLS000093715 | cid_...)
Affinity DataEC50:  163nMAssay Description:Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50008022(CHEMBL28045 | (4-methoxyphenyl)(3-morpholinomethyl...)
Affinity DataIC50: 0.320nMAssay Description:Agonist activity at CB1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetAmine oxidase [flavin-containing] B(Mouse)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589703(CHEMBL5196906)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of mouse muscle MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50246766(Mofegiline | CHEMBL489079 | US9302986, Mofegiline)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589700(CHEMBL5204901)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589702(CHEMBL5186190)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetCannabinoid receptor 1(Human)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM21281(WIN55212-2 | CHEMBL188 | (2,3-dihydro-5-methyl-3-(...)
Affinity DataIC50: 2nMAssay Description:Agonist activity at CB1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589698(CHEMBL5199917)
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589699(CHEMBL5197971)
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589695(CHEMBL5198317)
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589695(CHEMBL5198317)
Affinity DataIC50: 4nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50246766(Mofegiline | CHEMBL489079 | US9302986, Mofegiline)
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:Recombinant human MAO-B (0.06 mg/mL; Sigma Aldrich) was used as source of MAO-B enzyme activities. The assay was performed in a similar way as for hu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589700(CHEMBL5204901)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589703(CHEMBL5196906)
Affinity DataIC50: 5nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMembrane primary amine oxidase(Rat)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589703(CHEMBL5196906)
Affinity DataIC50: 5nMAssay Description:Inhibition of rat SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589696(CHEMBL5201033)
Affinity DataIC50: 6nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589696(CHEMBL5201033)
Affinity DataIC50: 9nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50246766(Mofegiline | CHEMBL489079 | US9302986, Mofegiline)
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589702(CHEMBL5186190)
Affinity DataIC50: 11nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589699(CHEMBL5197971)
Affinity DataIC50: 12nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589697(CHEMBL5194056)
Affinity DataIC50: 13nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589697(CHEMBL5194056)
Affinity DataIC50: 19nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589703(CHEMBL5196906)
Affinity DataIC50: 19nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589701(CHEMBL5186898)
Affinity DataIC50: 26nMAssay Description:Inhibition of human recombinant MAO-BMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589703(CHEMBL5196906)
Affinity DataIC50: 29nMAssay Description:Inhibition of SSAO in HMEC cellsMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589701(CHEMBL5186898)
Affinity DataIC50: 32nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM220861(US9302986, 4)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Recombinant human MAO-B (0.06 mg/mL; Sigma Aldrich) was used as source of MAO-B enzyme activities. The assay was performed in a similar way as for hu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM220871(US9302986, 13)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Recombinant human MAO-B (0.06 mg/mL; Sigma Aldrich) was used as source of MAO-B enzyme activities. The assay was performed in a similar way as for hu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM220884(US9302986, 18)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Recombinant human MAO-B (0.06 mg/mL; Sigma Aldrich) was used as source of MAO-B enzyme activities. The assay was performed in a similar way as for hu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDiamine oxidase [copper-containing](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM220869(US9302986, 2)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Recombinant human DAO (2.4 μg/mL) was used as source of DAO enzyme activities. The assay was performed as described in the method for human SSAO/V...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDiamine oxidase [copper-containing](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM220884(US9302986, 18)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Recombinant human DAO (2.4 μg/mL) was used as source of DAO enzyme activities. The assay was performed as described in the method for human SSAO/V...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589700(CHEMBL5204901)
Affinity DataIC50: 100nMAssay Description:Inhibition of human recombinant MAO-AMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589698(CHEMBL5199917)
Affinity DataIC50: 160nMAssay Description:Inhibition of human recombinant MAO-AMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetCannabinoid receptor 1(Rat)
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50251194(4-(2-(3-(3-Phenyl-1,2,4-oxadiazol-5-yl)-1H-indol-1...)
Affinity DataIC50: 250nMAssay Description:Displacement of [3H]SR141716A from CB1 receptor in Sprague-Dawley rat cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetAmine oxidase [copper-containing] 2(Human)
Pharmaxis

Curated by ChEMBL
LigandPNGBDBM50589698(CHEMBL5199917)
Affinity DataIC50: 288nMAssay Description:Inhibition of recombinant human SSAOMore data for this Ligand-Target Pair
In DepthDetails
PubMed
Displayed 1 to 50 (of 1355 total ) | Next | Last >>
Jump to: